Investment Summary

Eight Roads Invests In BenchSci

On February 4, 2020, private equity firm Eight Roads invested in life science company BenchSci

Investment Highlights
  • This is Eight Roads’ 61st transaction in the Life Science sector.
  • This is Eight Roads’ 3rd transaction in Canada.
  • This is Eight Roads’ 2nd transaction in Ontario.

Investment Summary

Date 2020-02-04
Target BenchSci
Sector Life Science
Investor(s) Eight Roads
Deal Type Venture

Target

BenchSci

Toronto, Ontario, Canada
BenchSci develops research intelligence platform designed to accelerate biomedical discoveries. BenchSci was founded in 2015 and is based in Toronto Ontario.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Eight Roads

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1969
PE ASSETS 11.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.


DEAL STATS #
Overall 226 of 293
Sector: Life Science M&A 61 of 73
Type: Venture M&A Deals 203 of 266
State: Ontario M&A 2 of 2
Country: Canada M&A 3 of 3
Year: 2020 M&A 4 of 18
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-01-17 Funnel

Stockholm, Sweden

Funnel is an internationally operating company with a software as a service product for marketers and data teams. Funnel designs and develops software/platform that helps marketers automate their data collection. Funnel was founded in 2014 and is based in Stockholm, Sweden.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-02-05 Beam Therapeutics

Cambridge, Massachusetts, United States

Beam Therapeutics is a biotechnology company that builds a strong, values-driven organization focused on people, advancing cutting-edge science, and rigorously developing a new class of precision genetic medicines. The company engages in developing precision genetic medicines for patients suffering from serious diseases in the United States. Beam Therapeutics was founded in 2017 and is headquartered in Cambridge, Massachusetts.

Sell -